[VRTX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
23-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 178.74%
YoY- 143.63%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 1,413,265 870,106 651,634 458,706 417,935 144,556 351,157 26.10%
PBT 676,950 32,497 112,442 20,306 -77,829 -178,594 -340,253 -
Tax 93,716 -1,492,599 10,257 -7,453 -1,379 2,043 -155,704 -
NP 583,234 1,550,527 100,684 32,945 -75,512 -176,656 44,285 53.64%
Tax Rate -13.84% 4,593.04% -9.12% 36.70% - - - -
Total Cost 830,031 -680,421 550,950 425,761 493,447 321,212 306,872 18.02%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 41.27 178.20 15.45 7.18 -18.07 -122.21 12.61 21.83%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 2.26 6.08 0.40 0.13 -0.31 -0.74 0.19 51.05%
EPS Diluted 2.23 5.97 0.39 0.13 -0.31 -0.74 0.19 50.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.